http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007117544-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8f134a9917fb85a778574ce454a1c6ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8166be02dcec25904ea040c8fcfb2418
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2603-74
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C237-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-612
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C235-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-608
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-616
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-215
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-16
filingDate 2007-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_180796132b3999c08f1b17fd3d01ea9e
publicationDate 2008-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2007117544-A3
titleOfInvention Carnitine conjugates of adamantanamines and neramexane derivatives as duel prodrugs for various uses
abstract This invention concerns compounds of adamantanamines and neramexane, including their pharmaceutical ly-acceptable salts, diesterioisomers, and formulations for treating Alzheimer's related dementias, depression, AIDS related dementias, as antivirals, inflammatory diseases such as rheumatoid arthritis, and cerebral ischemia, hyperlipidemia, and diabetes.
priorityDate 2006-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005049312-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003114460-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411139
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2130
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419494653
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419589374
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505371
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6433106
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID288

Total number of triples: 37.